Condition: Healthy Volunteers Essential Hypertension · Sponsor: Kyowa Kirin Co., Ltd.
Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.
This description comes directly from the study's public registry record.
Kyowa Kirin Co., Ltd. · +81-3-5205-7200 · clinical.info.jp@kyowakirin.com
Always discuss trial participation with your own doctor first.
| SOUSEIKAI PS Clinic | Hakata, Fukuoka, Japan | Not Yet Recruiting |
| Medical Corporation Heishinkai OPHAC Hospital | Yodogawa, Osaka, Japan | Not Yet Recruiting |
| Kitasato University Kitasato Institute Hospital | Minato-ku, Tokyo, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06823947